Blood tumor load: combining biomarkers to increase the proportion of informative patients
In this study, we demonstrated the applications of BTL in improving the reliability of measuring response to therapy and increasing the proportion of patients from which the presence of a treatment target can be assessed.
Authors
- Leon W.M.M. Terstappen (ORCID: https://orcid.org/0000-0001-5944-3787)
- F.-C. Bidard
- Afroditi Nanou (ORCID: https://orcid.org/0000-0002-8682-3133)
- Frank Coumans (ORCID: https://orcid.org/0000-0001-6282-6009)
- Eshwari Dathathri (ORCID: https://orcid.org/0000-0001-9389-029X)
- Sylvaine Renault (ORCID: https://orcid.org/0000-0002-6980-8855)
- Johann Sebastian De Bono (ORCID: https://orcid.org/0000-0002-2034-595X)
- J-Y Pierga
Institutions
- Institute of Cancer Research (GB)
- Royal Marsden Hospital (GB)
- University of Twente (NL)
Publication Details
- Journal
- ESMO Open
- Published
- 2025-06-17
- DOI
- https://doi.org/10.1016/j.esmoop.2025.105302
- Citations
- 3
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 2.81
Funders
- Menarini Silicon Biosystems